Endoluminal Sciences

About:

Endoluminal Sciences develops novel platform technologies to enhance the clinical performance of endovascular prostheses.

Website: http://endoluminalsciences.com

Top Investors: Cicada Innovations

Description:

Endoluminal Sciences is an early stage venture capital-backed company, committed to the development of novel, platform technologies to dramatically enhance the clinical performance of endovascular prostheses. While the technology is foreseen to have its application to a range of vascular disease states, the immediate focus is the treatment of abdominal aortic aneurysms (AAAs).

Total Funding Amount:

$2.5M

Estimated Revenue Range:

$10M to $50M

Headquarters Location:

Sydney, New South Wales, Australia

Founded Date:

2007-01-01

Contact Email:

info(AT)endoluminalsciences.com

Founders:

Ashish Mitra

Number of Employees:

11-50

Last Funding Date:

2013-07-22

IPO Status:

Private

Industries:

© 2025 bioDAO.ai